# Pharmacological Effect of Lysozyme for Chronic Obstructive Pulmonary Disease and Asthma With Sputum Symptom

> **NCT01715493** · PHASE4 · COMPLETED · sponsor: **Eisai Co., Ltd.** · enrollment: 48 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease
- Asthma

## Interventions

- **DRUG:** lysozyme 90 mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01715493
- **Lead sponsor:** Eisai Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2013-12
- **Final completion:** 2014-01
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2014-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01715493

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01715493, "Pharmacological Effect of Lysozyme for Chronic Obstructive Pulmonary Disease and Asthma With Sputum Symptom". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01715493. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*